Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.
Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.
复制标题
DOI:
10.1016/j.celrep.2016.03.038
复制
发表时间:
2016-04-19
期刊:
影响因子:
8.8
通讯作者:
Huang H
中科院分区:
文献类型:
--
作者:
Zhao Y;Wang L;Ren S;Wang L;Blackburn PR;McNulty MS;Gao X;Qiao M;Vessella RL;Kohli M;Zhang J;Karnes RJ;Tindall DJ;Kim Y;MacLeod R;Ekker SC;Kang T;Sun Y;Huang H
The androgen receptor (AR) is required for castration resistant prostate cancer (CRPC) progression, but the function and disease relevance of AR-bound enhancers remain unclear. Here, we identify a group of AR-regulated enhancer RNAs (e.g. PSA eRNA) that are upregulated in CRPC cells, patient-derived xenografts (PDX) and patient tissues. PSA eRNA binds to CYCLIN T1, activates P-TEFb and promotes cis and trans target gene transcription by increasing serine-2 phosphorylation of RNA polymerase II (Pol II-Ser2p). We define an HIV-1 TAR RNA-like (TAR-L) motif in PSA eRNA that is required for CYCLIN T1 binding. Using TALEN-mediated gene editing we further demonstrate that this motif is essential for increased Pol II-Ser2p occupancy levels and CRPC cell growth. We have uncovered a P-TEFb activation mechanism and reveal altered eRNA expression that is related to abnormal AR function and may potentially be a therapeutic target in CRPC. Zhao et al. show that a group of AR-regulated eRNAs, including the PSA eRNA are upregulated in CRPC cells in culture as well as in patient specimens. The PSA eRNA binds to CYCLIN T1, activates P-TEFb and increases Pol II-Ser2p and cell growth, and this effect is mediated through a TAR-L motif.